$DCOY leaps on the Pan-Filovirus FDA pathway announcement. Catalyst-driven gap-ups close green 34% of the time. Also on the tape: #LHSW (Chery Group auto deal), #FLNA (FDA hold lifted). The non-dilutive funding clause is the real detail.
$HUBC -31.50% — what the base rate says
What the data showed
- $HUBC -31.50% mcap $250,000 · float 5M shares
- $SLXN -25.64% mcap $2M · float 6M shares · sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- $BTTC -24.51% mcap $13M · float 6M shares
- $CLDX -23.46% mcap $3.0B · float 78M shares · sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- $VRME -17.39% mcap $10M · float 11M shares · sector: FINANCE SERVICES
- $LOBO -15.00% mcap $8M · float 11M shares
- $CMPX -14.84% mcap $342M · float 143M shares · sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- $DAVA -13.62% mcap $208M · float 42M shares
- $XNDU -12.35% mcap $4.4B · float 9M shares
- $CELZ -11.90% mcap $6M · float 7M shares · sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Run the exact base-rate sample on FILTRIX.net before sizing into the next filing spike. Discipline > FOMO
Find Your Edge on FILTRIX →